BY: MOHAMED SAHR
In the battle against malaria, Sierra Leone stands at the forefront, grappling with the persistent threat posed by the disease, particularly among its most vulnerable demographics. With an estimated 6.5 million citizens vulnerable to malaria, and an alarming annual count of more than two million reported cases, the nation is waging a determined campaign to stem the tide of this deadly scourge.
The latest figures from the National Malaria Control Programme underscore the enduring transmission of malaria throughout Sierra Leone, highlighting the nation’s susceptibility to this potential killer. Among the most severely affected are children under five and pregnant women, whose heightened risk stems from a combination of factors including immature immune systems and increased susceptibility during pregnancy.
Tragically, statistics reveal the devastating toll malaria exacts on these demographics. In 2023 alone, over 1,500 children under the age of five succumbed to malaria, while nearly 27,000 were hospitalized due to the disease. Pregnant women, too, face dire consequences, with malaria increasing the risk of preterm birth and low birth weight, contributing significantly to neonatal and infant mortality rates.
Despite strides made in malaria prevention and treatment, Sierra Leone continues to grapple with significant challenges. The World Health Organization (WHO) reports a substantial resurgence in malaria deaths between 2010 and 2015, with the Western Area bearing the brunt of this setback. However, efforts to combat malaria have not been in vain, with interventions such as diagnostic tests, free treatment, and mass distribution of insecticide-treated nets (ITNs) making a tangible impact on reducing mortality rates.
In a landmark development, Sierra Leone is set to roll out a groundbreaking initiative to combat malaria among its most vulnerable citizens. A recent population census has paved the way for the distribution of five hundred and fifty thousand malaria vaccines, targeting children under five. Dr. Desmond Maada Kangbai, Program Manager for the Expanded Programme Immunization of the Ministry of Health, underscores the significance of this vaccine distribution, emphasizing its alignment with population demographics to ensure maximum coverage.
However, challenges persist on the path to malaria eradication. WHO reports that only 31% of pregnant women in sub-Saharan Africa receive the recommended three doses of the Intermittent Prevention Treatment in pregnancy (IPTp) vaccine, underscoring the urgent need for expanded access to preventive measures.
In response to these challenges, Sierra Leone’s Ministry of Health has pledged to reduce malaria infections among children under five and pregnant women by 40 percent. This ambitious goal hinges on collaborative efforts from government, health professionals, partners, and community stakeholders to ensure adherence to preventive measures and treatment protocols.
As Sierra Leone confronts the formidable challenge of malaria, the nation’s resolve remains unwavering. With concerted action and unwavering commitment, Sierra Leone aims to turn the tide against malaria, safeguarding the health and well-being of its most vulnerable citizens for generations to come.
